Concepedia

Paula I. González-Ericsson

PI

48

Publications

5.5K

Citations

33

H-Index

2017

Active since

Affiliations

Vanderbilt University Medical Center(Current)

Vanderbilt University

The University of Texas Southwestern Medical Center

Breast Cancer Research Foundation

Dana-Farber Cancer Institute

Paula I. González-Ericsson is an author at Vanderbilt University Medical Center specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2017–2024

48

Publications

48

Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data

Francesca Finotello, Clemens Mayer, Christina Plattner et al. · Genome Medicine · 2019 · 1.6K citations · Full text

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

Luigi Formisano, Yao Lu, Alberto Servetto et al. · Nature Communications · 2019 · 383 citations · Full text

DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer

Na Luo, Mellissa J. Nixon, Paula I. González-Ericsson et al. · Nature Communications · 2018 · 254 citations · Full text

Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes

Brian D. Lehmann, Antonio Colaprico, Tiago C. Silva et al. · Nature Communications · 2021 · 244 citations · Full text

Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Valerie M. Jansen, Neil E. Bhola, Joshua A. Bauer et al. · Cancer Research · 2017 · 224 citations · Full text

Rows per page

1–5 of 48